Polyrizon Ltd. News

Latest Polyrizon Ltd. Stock News & PLRZ Headlines

POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN

6 days ago | globenewswire.com

Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker

20 days ago | globenewswire.com

Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform

a month ago | globenewswire.com

Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker

2 months ago | globenewswire.com

Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement

2 months ago | globenewswire.com

Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement

2 months ago | globenewswire.com

Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study

2 months ago | globenewswire.com

Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment

3 months ago | globenewswire.com

Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial

4 months ago | globenewswire.com

Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial

4 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

PLRZ

Polyrizon Ltd.

$ 11.05

-3.75%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Polyrizon Ltd. News

Latest Polyrizon Ltd. Stock News & PLRZ Headlines

Download App

People Also Watch

Explore our Tools